NCT02226276 2026-02-13
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
City of Hope Medical Center
Phase NA Active not recruiting
City of Hope Medical Center
Thomas Jefferson University
Peking University Cancer Hospital & Institute
University of Washington
University of Washington
Centre Georges Francois Leclerc
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)